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ETTERS TO THE EDITOR
ymphomatoid granulomatosis
-  A rare pulmonary
lesser  degree  EVB-positive  B-lymphocytes  proportion  help  to
classify  the  disease  (grade  1--3)  and  give  a  prognostic  value.6w
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uymphoproliferative disease
ear  Editor,
ymphomatoid  granulomatosis  (LYG)  is  a  rare  Epstein--Barr
irus-driven  lymphoproliferative  disorder.1 It  affects  middle-
ged  adult  males  more  often  than  females  (M:F  ratio  ≥  2:1)
nd  patients  with  underlying  immunodeﬁciency  are  at
ncreased  risk.2
Pulmonary  involvement  occurs  in  over  90%  of  the  patients
nd  is  usually  present  at  initial  diagnosis.  Other  common
ites  of  involvement  include  the  skin,  peripheral  and  cen-
ral  nervous  system,  kidney  and  liver,  whereas,  the  upper
espiratory  and  gastrointestinal  tract,  lymph  nodes,  bone
arrow  and  spleen  may  be  also  affected,  but  are  relatively
ncommon.3,4
Cough,  chest  pain  and  dyspnea  are  the  main  pulmonary
ymptoms  and,  hemoptysis  usually  indicates  cavitation
f  the  nodules.  Constitutional  symptoms  including,  fever,
sthenia,  night  sweats  and  weight  loss  are  common  and  few
atients  present  with  asymptomatic  disease.4,5
Typical  radiographic  features  are  multiple  bilateral  lung
odules  (80%),  with  predominant  basal  and  peribronchovas-
ular  distribution,  that  can  progress  rapidly,  coalesce  and
ommonly  cavitate.  Additionally,  LYG  may  present  as  pul-
onary  cystic  lesion,  pleural-based  mass  or  prominent
nterstitial  process.5
LYG  histological  evaluation  is  characterized  by  an  angio-
entric  and  angiodestructive  inﬁltrating  process,  comprised
f  a  mixture  of  small  and  large  lymphocytes  with  variable
ytologic  atypia,  histiocytes,  and  occasional  plasma  cells,
acking  true  granulomatous  architecture.3,4 The  inﬁltrate
hows  a  predilection  for  vascular  involvement  and  necro-
is  may  be  present3,  and  demonstration  of  EBV  RNA  genome
r  protein  is  a  crucial  point  for  correct  diagnosis  of  LYG.
Despite  relatively  little  evidence-based  data,  the  WHO
ecommends  that  LG  be  graded  in  three  different  histologic
ypes,  according  to  the  number  of  EBV-positive  large  B  cells.
his  classiﬁcation  must  be  interpreted  with  caution,  due  to
onsiderable  diversity  in  sampling  from  the  same  individual
nd  the  possibility  of  different  grades  coexisting  in  the  same
ample.  Atypical  large  B-lymphocytes  proportion  and  to  a
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nder the CC BY-NC-ND license (http://creativecommons.org/licenses/bWe  report  a  case  of  a  68-year-old  male,  former  smoker
ith  a medical  history  of  cardiac  heart  failure,  coronary
eart  disease,  atrial  ﬁbrillation,  type  2  diabetes,  primary
rterial  hypertension  and  dyslipidemia.
The  patient  was  admitted  to  the  emergency  department
ith  recurrent  syncopal  events.  Cranial  computed  tomogra-
hy  scan  (CT  scan)  was  unremarkable  and  CT  pulmonary
ngiography  revealed  a  pulmonary  mass.
Chest  and  abdominal  CT  scan  showed  a  mass  of
.3  cm  ×  3.7  cm  in  the  lingular  segment,  and  three  satellite
odules,  the  largest  of  which  was  2  cm  in  diameter.  Several
nlarged  lymph  nodes  were  identiﬁed  (pre-vascular,  para-
racheal,  subcarinal  and  left  hilar)  (Fig.  1A).  Whole-body
ET  scan  revealed  high  FDG  uptake  in  the  pulmonary  mass,
s  well  as,  in  two  satellites  nodules,  in  the  left  bronchohilar,
ediastinal  and  right  paratracheal  lymph  nodes  and  in  the
pleen.
CT-guided  transthoracic  core  needle  biopsy  was  per-
ormed  and  the  histopathological  examination  revealed  an
nterstitial  polymorphic  inﬁltrate  of  small  T  lymphocytes
nd  large  atypical  B  lymphocytes,  with  vascular  wall  perme-
tion.  The  expression  of  EBV  protein  was  identiﬁed  in  some
f  the  large  lymphocytes  with  imunnohistochemical  staining
5--20  cells  per  high-power  ﬁeld),  also  present  in  vascular
alls  (Fig.  1B--D).  A  diagnosis  of  lymphomatoid  granulomato-
is  (grade  2)  was  established  and  the  patient  was  referred
o  the  Hematology  department.
The  clinical  course  of  LYG  is  variable.  Some  patients
ollow  a waxing  and  waning  clinical  course  with  rare  spon-
aneous  remissions  without  therapy.  However,  based  on
istorical  series,  the  majority  of  patients  have  progressive
isease,  with  a  median  survival  of  two  years.  Predictors
f  poor  prognosis  are  central  nervous  system  involvement,
rade  3,  young  age  at  diagnosis  (<25  years),  leukocytosis  and
epatomegaly.7
No  standard  therapy  has  been  established,  and  treatment
epends  on  histologic  ﬁndings  as  well  as  the  extent  and  loca-
ion  of  the  disease.  Grades  1  and  2  lesions  may  achieve
urable  responses  to  interferon- 2b,  whereas  grade  3  is
sually  approached  as  diffuse  large  B-cell  lymphoma.8The  authors  present  this  case  report  based  on  its  rar-
ty  and  because  it  still  remains  relatively  poorly  recognized
y  clinicians  and  pathologists.5 Controversy  still  exists
iedade Portuguesa de Pneumologia. This is an open access article
y-nc-nd/4.0/).
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Figure  1  (A)  Chest  CT  scan  showing  a  mass  of  4.3  cm  ×  3.7  cm  in  the  lingular  segment.  (B)  (HE  100×) --  Polymorphic  inﬁltrate
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(A.  Gonc¸alves).in walls  of  blood  vessels  and  alveoli,  including  large  lymphocyt
CD20+ B  lymphocytes.  (D)  EBV-positive  large  atypical  B  cells.
concerning  diagnostic  criteria,  precise  taxonomy,  treatment
and  relationship  to  other  lymphoproliferative  diseases.4
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